Breast Cancer Trial, Recruiting (NCT06572410)

Breast Cancer Trial, Recruiting NCT06572410 Sponsor: Elucent Medical Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06572410 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a breast lesion that can be seen and identified on a medical scan or image.
You have chosen to have a lumpectomy (surgery to remove only the tumor, not the whole breast), possibly along with radiation, chemotherapy, or hormonal/targeted treatments.
You will be having a special clip called a "SmartClip" placed to mark the area of tissue to be removed during surgery.
You will be having your breast-conserving surgery guided by a specific medical device called the EnVisio® Navigation System, for either a non-invasive or invasive form of breast cancer.
You are 18 years of age or older.
If you are not able to give consent yourself, a legally authorized representative is able to give consent on your behalf.

Who may not be able to join:

You are having a full breast removal (mastectomy) to treat the targeted lesion.
The area to be removed is being marked or located using a different method other than the SmartClip.
You are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 352-243-2622

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06572410

Sponsor: Elucent Medical

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: 352-243-2622

More information: https://clinicaltrials.gov/study/NCT06572410

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a breast lesion that can be seen and identified on a medical scan or image.
You have chosen to have a lumpectomy (surgery to remove only the tumor, not the whole breast), possibly along with radiation, chemotherapy, or hormonal/targeted treatments.
You will be having a special clip called a "SmartClip" placed to mark the area of tissue to be removed during surgery.
You will be having your breast-conserving surgery guided by a specific medical device called the EnVisio® Navigation System, for either a non-invasive or invasive form of breast cancer.
You are 18 years of age or older.
If you are not able to give consent yourself, a legally authorized representative is able to give consent on your behalf.

Who may not be able to join:

You are having a full breast removal (mastectomy) to treat the targeted lesion.
The area to be removed is being marked or located using a different method other than the SmartClip.
You are currently pregnant.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Elucent Medical

Registry

ClinicalTrials.gov

Start date

7 August 2024

Est. completion

1 February 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Margin Positivity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov